US 2013/0156725 A1Published application

Random pentapolymer for treatment of autoimmune diseases

AssigneeMapi Pharma Ltd.

InventorsEhud MAROM, Shai RUBNOV

Life of this patent

Estimating the term…

Abstract

The present invention relates to a synthetic polypeptide which is a random linear pentapolymer comprising alanine, glutamic acid, lysine, tyrosine and phenylalanine and use thereof in treating autoimmune diseases, in particular multiple sclerosis.

Claims17

Dependent claims

1-26. (canceled)

Dependencies are inferred from the claim text.

Facts

Application: 13/764,460Filed 11 Feb 2013
Priority: 21 Apr 2011
Published: 20 Jun 2013
Term ends: Not estimatedThe source records don’t support an estimate.

Classification10 codes

C08G 69/10
Derived from amino-carboxylic acids: alpha-amino-carboxylic acids
A61K 31/785
Synthetic polymeric materials: polymers containing nitrogen
A61K 45/06
Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00: mixtures of active ingredients without…
A61P 25/28
Drugs for disorders of the nervous system: for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents,…

Family

Application61/477,610Us provisional application · filed 21 Apr 2011
Application13/764,460Continuation
US 9,200,114 B2Related patent
US 2013/0156725 A1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

Building an agent or pulling many patents? Use the API or MCP server instead of scraping pages. Get an API key

patentgrep

Loading patent…

patentgrepSearch patents

Back to results